Product Information
- (S)-2-Benzyl-4-oxo-4-(cis-perhydroisoindol-2-yl)butyric Acid-d8 Calcium Salt Hydrate
- Mitiglinide-d8 Calcium Hydrate
Applications KAD-1229 binds to sulfonylurea receptors and inhibits the activity of ATP-sensitive K+ channel in MIN 6 cells. Antidiabetic.
References Jackson, J., et al.: Drugs, 22, 211 (1981), Mogami, H., et al.: Eur. J. Pharmacol., 15, 269, (1994), Malaisse, W., et al.: Pharmacol. Res. 32, 111 (1995), Ulusoy, S., et al.: Diabetes Res., 31, 27 (1996), Louchami, K., et al.: Pharmacol. Res., 40, 297 (1999),
Chemical properties
Technical inquiry about: TR-K090002 KAD-1229-d8 Calcium Hydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.